A Study On Financial Performance Of Caplin Point Laboratories Limited

This study analyses the financial performance of Caplin Point Laboratories Limited, a rapidly growing pharmaceutical company headquartered in Chennai, India. The research examines the company’s financial health over a five-year period (2019–2023) using key financial indicators such as net profit, net worth, dividend trends, and financial ratios. The study employs trend analysis and ratio analysis to assess profitability, liquidity, and overall financial stability. Findings indicate that Caplin Point Laboratories has exhibited strong financial growth, with increasing net profit, rising net worth, and consistent dividend payouts. The net profit ratio improved significantly, reaching 44.31% in 2023, while net worth more than doubled over the five-year period. However, the working capital turnover ratio declined, indicating potential inefficiencies in short-term asset management. The company’s proprietary ratio remained stable, reflecting a strong reliance on equity financing. .